Structure (Glimepiride Tabs Usp 1 mg 2 mg 4 mg Micro Labs 1)
Glimepiride Tablet
Product Images NDC 0615-8334
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 0615-8334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Inc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel Glimepiride 1 mg (Glimepiride Tabs Usp 1 mg 2 mg 4 mg Micro Labs 2)
A description is not available as the text seems to be a medicine label and does not provide any useful information.*
Principal Display Panel Glimepiride 2 mg (Glimepiride Tabs Usp 1 mg 2 mg 4 mg Micro Labs 3)
This is a package of Glimepiride tablets manufactured by Micro Labs. The package contains 30 tablets of 2mg, with Lot number 8333-39 and expiry date not specified. The tablets are intended for daily use and must be stored at 68°F to 77°F. The package insert or label should be consulted for dosage information.*
Principal Display Panel Glimepiride 4 mg (Glimepiride Tabs Usp 1 mg 2 mg 4 mg Micro Labs 4)
This is a packaging description for Glimepiride tablets containing information such as batch number, manufacturing date, dosage, and storage instructions. The packaging is manufactured by Micro Labs, and the package must be stored at room temperature. The instructions also indicate that the tablets must be dispensed in a well-closed container and for institutional use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
